{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:01:18Z","timestamp":1773802878863,"version":"3.50.1"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["ACAMC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Due to the emergence of resistance to available anticancer agents, the demand for new cytotoxic\nagents has grown.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This study aims at synthesis and cytotoxic evaluation of new acrylic acid derivatives bearing quinolinone\nand halogenated quinolinone derivatives against three cancer cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>New acrylic acid derivatives bearing quinolinone and halogenated quinolinone moieties were synthesized\nand screened for their cytotoxic activity against breast MCF-7, liver HepG2, and colon HCT-116 cancer cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Molecules 3 and 8 showed the most potent cytotoxic activity against HCT-116. DNA flow cytometry assay\nshowed cell cycle arrest at the G1 phase and cellular apoptosis. Moreover, molecules 3 and 8 showed cyclin-dependent\nkinase 2 (CDK2) inhibitory activity compared to the untreated control sample.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Acrylic acid derivatives bearing quinolinone and halogenated quinolinone moieties represent an important\ncore and could be used as a lead for further development of drug compounds in order to achieve promising therapeutic\nresults.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871520621666211103105255","type":"journal-article","created":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T06:18:12Z","timestamp":1636006692000},"page":"1634-1642","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In Vitro Antitumor Evaluation of Acrylic Acid Derivatives Bearing Quinolinone Moiety as Novel Anticancer Agents"],"prefix":"10.2174","volume":"22","author":[{"given":"Islam","family":"Zaki","sequence":"first","affiliation":[{"name":"Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Port Said University, Port Said, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.","family":"Eid","sequence":"additional","affiliation":[{"name":"Chemistry Department, Faculty of Science, Port-said University, Port Said, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed S.","family":"Elghareb","sequence":"additional","affiliation":[{"name":"Chemistry Department, Faculty of Science, Port-said University, Port Said, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al-Shimaa M.","family":"Abas","sequence":"additional","affiliation":[{"name":"Chemistry Department (Biochemistry Branch), Faculty of Science,\nZagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber","family":"Mersal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Science, Taif University, Taif 26571, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faten Z.","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Chemistry Department (Biochemistry Branch), Faculty of Science,\nZagazig University, Zagazig, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.redox.2020.101737","volume":"37","author":"L\u00f3pez-Grueso M.J.","year":"2020","unstructured":"L\u00f3pez-Grueso M.J.; Lagal D.J.; Garc\u00eda-Jim\u00e9nez \u00c1.F.; Tarradas R.M.; Carmona-Hidalgo B.; Peinado J.; Requejo-Aguilar R.; B\u00e1rcena J.A.; Padilla C.A.; Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2\/M in HepG2 hepatocarcinoma cells. Redox Biol 2020,37,101737","journal-title":"Redox Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"Kent L.N.","year":"2019","unstructured":"Kent L.N.; Leone G.; The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer 2019,19(6),326-338","journal-title":"Nat Rev Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12013-020-00919-0","volume":"78","author":"Mast J.M.","year":"2020","unstructured":"Mast J.M.; Hinds J.W.; Tse D.; Axelrod K.; Kuppusamy M.L.; Kmiec M.M.; Bogn\u00e1r B.; K\u00e1lai T.; Kuppusamy P.; Selective induction of cellular toxicity and anti-tumor efficacy by n-methylpiperazinyl diarylidenylpiperidone and its pro-nitroxide conjugate through ROS-mediated mitochondrial dysfunction and G2\/M cell-cycle arrest in human pancreatic cancer. Cell Biochem Biophys 2020,78(2),191-202","journal-title":"Cell Biochem Biophys"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1080\/07391102.2019.1696709","volume":"38","author":"Singh R.","year":"2020","unstructured":"Singh R.; Bhardwaj V.; Das P.; Purohit R.; Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective. J Biomol Struct Dyn 2020,38(17),5126-5135","journal-title":"J Biomol Struct Dyn"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"8001","DOI":"10.1073\/pnas.1912617117","volume":"117","author":"Sharma S.","year":"2020","unstructured":"Sharma S.; Zhang T.; Michowski W.; Rebecca V.W.; Xiao M.; Ferretti R.; Suski J.M.; Bronson R.T.; Paulo J.A.; Frederick D.; Fassl A.; Boland G.M.; Geng Y.; Lees J.A.; Medema R.H.; Herlyn M.; Gygi S.P.; Sicinski P.; Targeting the cyclin-dependent kinase 5 in metastatic melanoma. Proc Natl Acad Sci USA 2020,117(14),8001-8012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=6","first-page":"306","volume":"43","author":"Yamamura M.","year":"2020","unstructured":"Yamamura M.; Sato Y.; Takahashi K.; Sasaki M.; Harada K.; The cyclin dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma. Oncol Rep 2020,43(1),306-317","journal-title":"Oncol Rep"},{"key":"ref=7","first-page":"1","author":"Sarkar B.","year":"2020","unstructured":"Sarkar B.; Ullah M.A.; Islam S.S.; Rahman M.D.H.; Araf Y.; Analysis of plant-derived phytochemicals as anti-cancer agents targeting cyclin dependent kinase-2, human topoisomerase IIa and vascular endothelial growth factor receptor-2. J. Recept. Signal Transduction 2020,1-17"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/1878-0261.12148","volume":"12","author":"Whittaker S.R.","year":"2018","unstructured":"Whittaker S.R.; Barlow C.; Martin M.P.; Mancusi C.; Wagner S.; Self A.; Barrie E.; Te Poele R.; Sharp S.; Brown N.; Wilson S.; Jackson W.; Fischer P.M.; Clarke P.A.; Walton M.I.; McDonald E.; Blagg J.; Noble M.; Garrett M.D.; Workman P.; Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor. Mol Oncol 2018,12(3),287-304","journal-title":"Mol Oncol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/bjd.18178","volume":"182","author":"Henri P.","year":"2020","unstructured":"Henri P.; Prevel C.; Pellerano M.; Lacotte J.; Stoebner P.E.; Morris M.C.; Meunier L.; Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity. Br J Dermatol 2020,182(3),678-689","journal-title":"Br J Dermatol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","volume":"7","author":"Feelders R.A.","year":"2019","unstructured":"Feelders R.A.; Newell-Price J.; Pivonello R.; Nieman L.K.; Hofland L.J.; Lacroix A.; Advances in the medical treatment of Cushing\u2019s syndrome. Lancet Diabetes Endocrinol 2019,7(4),300-312","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/ijms21061960","volume":"21","author":"Ding L.","year":"2020","unstructured":"Ding L.; Cao J.; Lin W.; Chen H.; Xiong X.; Ao H.; Yu M.; Lin J.; Cui Q.; The roles of cyclin-dependent kinases in cell-cycle progression and therapeutic strategies in human breast cancer. Int J Mol Sci 2020,21(6),1960","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1002\/cam4.818","volume":"5","author":"Liu F-Y.","year":"2016","unstructured":"Liu F-Y.; Wang L-P.; Wang Q.; Han P.; Zhuang W-P.; Li M-J.; Yuan H.; miR-302b regulates cell cycles by targeting CDK2 via ERK signaling pathway in gastric cancer. Cancer Med 2016,5(9),2302-2313","journal-title":"Cancer Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"104616","DOI":"10.1016\/j.phrs.2019.104616","volume":"152","author":"Sun Y-S.","year":"2020","unstructured":"Sun Y-S.; Thakur K.; Hu F.; Zhang J-G.; Wei Z-J.; Icariside II inhibits tumorigenesis via inhibiting AKT\/Cyclin E\/CDK 2 pathway and activating mitochondria-dependent pathway. Pharmacol Res 2020,152,104616","journal-title":"Pharmacol Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1134\/S1068162020060096","volume":"46","author":"Zaki I.","year":"2020","unstructured":"Zaki I.; Imam A.; Design, synthesis, and cytotoxic screening of new quinoline derivatives over MCF-7 breast cancer cell line. Russ J Bioorganic Chem 2020,46(6),1099-1109","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3390\/cryst11050565","volume":"11","author":"Gaber A.","year":"2021","unstructured":"Gaber A.; Alsanie W.F.; Alhomrani M.; Alamri A.S.; El-Deen I.M.; Refat M.S.; Synthesis and characterization of some new coumarin derivatives as probable breast anticancer MCF-7 drugs. Cryst 2021,11(5),565-578","journal-title":"Cryst"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1021\/acs.orglett.0c01469","volume":"22","author":"Li J-J.","year":"2020","unstructured":"Li J-J.; Wang C-G.; Yu J-F.; Wang P.; Yu J-Q.; Cu-catalyzed C-H alkenylation of benzoic acid and acrylic acid derivatives with vinyl boronates. Org Lett 2020,22(12),4692-4696","journal-title":"Org Lett"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/cryst11050571","volume":"11","author":"Gaber A.","year":"2021","unstructured":"Gaber A.; Alsanie W.F.; Alhomrani M.; Alamri A.S.; El-Deen I.M.; Refat M.S.; Synthesis of 1-[(Aryl)(3-amino-5-oxopyrazolidin-4-ylidene) methyl]-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Derivatives and Their Breast Anticancer Activity. Cryst 2021,11(5),571-582","journal-title":"Cryst"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2174\/1871520620666200811122753","volume":"20","author":"El-Aziz R.M.A.","year":"2020","unstructured":"El-Aziz R.M.A.; Zaki I.; El-Deen I.M.; Abd-Rahman M.S.; Mohammed F.Z.; In vitro anticancer evaluation of some synthesized 2H-quinolinone and halogenated 2H-quinolinone derivatives as therapeutic agents. Anticancer Agents Med Chem 2020,20(18),2304-2315","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"e2000121","DOI":"10.1002\/ardp.202000121","volume":"353","author":"Zaki I.","year":"2020","unstructured":"Zaki I.; Ramadan H.M.M.; El-Sayed E.H.; Abd El-Moneim M.; Design, synthesis, and cytotoxicity screening of new synthesized imidazolidine-2-thiones as VEGFR-2 enzyme inhibitors. Arch Pharm (Weinheim) 2020,353(11),e2000121","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1134\/S1068162020030097","volume":"46","author":"Adil A.G.","year":"2020","unstructured":"Adil A.G.; Synthesis and Biological Evaluation of Some N-Substituted Quinoxaline Derivatives as Antitumor Agents. Russ J Bioorganic Chem 2020,46(3),409-416","journal-title":"Russ J Bioorganic Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bioorg.2018.12.007","volume":"84","author":"Mohamed K.O.","year":"2019","unstructured":"Mohamed K.O.; Zaki I.; El-Deen I.M.; Abdelhameid M.K.; A new class of diamide scaffold: Design, synthesis and biological evaluation as potent antimitotic agents, tubulin polymerization inhibition and apoptosis inducing activity studies. Bioorg Chem 2019,84,399-409","journal-title":"Bioorg Chem"},{"key":"ref=22","unstructured":"3DDQ. Available from:"},{"key":"ref=23","first-page":"67","volume":"5","author":"Chavan O.S.","year":"2014","unstructured":"Chavan O.S.; Baseer M.A.; Comparative study of various synthetic methods of 7-hydroxy-4-methyl coumarins via Pechmann reaction. Chem Sinica 2014,5(5),67-70","journal-title":"Chem Sinica"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s11164-019-03827-y","volume":"45","author":"Moustafa A.M.Y.","year":"2019","unstructured":"Moustafa A.M.Y.; Bakare S.B.; Synthesis of some hybrid 7-hydroxy quinolinone derivatives as anti breast cancer drugs. Res Chem Intermed 2019,45(7),3895-3912","journal-title":"Res Chem Intermed"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ejmech.2018.07.003","volume":"156","author":"Zaki I.","year":"2018","unstructured":"Zaki I.; Abdelhameid M.K.; El-Deen I.M.; Abdel Wahab A.H.A.; Ashmawy A.M.; Mohamed K.O.; Design, synthesis and screening of 1, 2, 4-triazinone derivatives as potential antitumor agents with apoptosis inducing activity on MCF-7 breast cancer cell line. Eur J Med Chem 2018,156,563-579","journal-title":"Eur J Med Chem"}],"container-title":["Anti-Cancer Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666211103105255","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197641\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871520621666211103105255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T01:38:25Z","timestamp":1659404305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197641\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871520621666211103105255","relation":{},"ISSN":["1871-5206"],"issn-type":[{"value":"1871-5206","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}